The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

The FDA suggests that prescribed users also reduce their calorie intake and increase their exercise The weight loss drug ...

This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec ... "Zepbound promotes weight loss and has been shown to reduce apnea ...

The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug ...

Connecticut law requires Medicaid to cover certain weight loss drugs, but officials say it hasn't been happening due to cost ...

The FDA approval for sleep apnea is ... That equates to 45 to 50 pounds of weight loss, on average, over a year, Lilly said. Patients on the drug also saw reductions in blood pressure and ...